Journal
IMMUNOLOGIC RESEARCH
Volume 22, Issue 2-3, Pages 281-298Publisher
HUMANA PRESS INC
DOI: 10.1385/IR:22:2-3:281
Keywords
B lymphocyte; CD19; Lyn; Vav; CD22; signal transduction
Categories
Funding
- NCI NIH HHS [CA81776, CA54464] Funding Source: Medline
- NATIONAL CANCER INSTITUTE [R01CA054464, R01CA081776, R55CA054464] Funding Source: NIH RePORTER
Ask authors/readers for more resources
The fate of B lymphocytes is dependent on intrinsic and B cell antigen receptor (BCR)-induced signals. These signals are interpreted and modified by response regulators such as CD19 that govern mature B cell activation. The current understanding of how CD19 governs B lymphocyte signaling is outlined in this review. Primarily, CD19 establishes a novel Src-family kinase amplification loop that regulates basal signal transduction thresholds in resting B cells. Moreover, CD19 amplifies Src-family kinase activation following BCR ligation. CD19 amplification of Lyn activity leads to processive phosphorylation of CD19 and downstream substrates including CD22. Phosphorylated CD19 recruits other effector molecules including Vav, Grb2, phosphoinositide 3-kinase, phospholipase C gamma2, and c-Abl, which may contribute to CD19 regulation of B cell function. CD19/Lyn complex formation also regulates phosphorylation of CD22 and Fc gamma RIIB, which inhibit B cell signal transduction through the recruitment of the SHP1 and SHIP phosphatases. These observations provide insight into how CD19 governs the molecular ordering and intensity of signals transduced in B cells, and how perturbations in CD19 expression or signaling function may contribute to autoimmunity.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available